DESCRIPTION: The long range goal of this project is to determine whether
androgen receptor (AR) mutations/polymorphisms can be used as a functional
biomarker of prostate cancer development or progression. The applicant
theorized that androgen independent tumors have escaped androgen control
because the receptor has become functionally activated because of gene
mutation. Her preliminary studies have shown that androgen receptor
mutations frequently occur in advanced prostate cancer, the proposal seeks
support to define whether androgen receptor mutations/polymorphisms can be
used as a functional biomarker of prostate cancer development or
progression by defining the incidence and type of mutations associated
with prostate cancer. It is imperative that the functional significance of
these mutations be defined. These studies will define the significance of
androgen receptor mutations in the development/progression of prostate
cancer and validate their application as biomarkers.
Error Notice
The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.
We apologize for the inconvenience.
- The DCCPS Team.